Equities

Shofu Inc

7979:TYO

Shofu Inc

Actions
Health CareMedical Equipment and Services
  • Price (JPY)4,925.00
  • Today's Change180.00 / 3.79%
  • Shares traded106.70k
  • 1 Year change+115.63%
  • Beta0.6190
Data delayed at least 20 minutes, as of Jul 04 2024 07:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

SHOFU INC. is a Japan-based company mainly engaged in the manufacture and sale of dental materials and equipment. The Company operates in three business segments. The Dental-related segment is engaged in the manufacture and sale of prosthetic tooth materials, abrasive materials, metals, chemicals, cement, as well as various equipment and tools. The Nail-related segment is engaged in the manufacture and sale of nail care products. The Others segment is engaged in the manufacture and sale of industrial abrasives.

  • Revenue in JPY (TTM)35.08bn
  • Net income in JPY3.66bn
  • Incorporated1922
  • Employees1.37k
  • Location
    Shofu Inc800, Yamada-cho, Higashiyama-kuKYOTO-SHI 605-0983JapanJPN
  • Phone+81 755611112
  • Fax+81 755611747
  • Websitehttps://www.shofu.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CI Medical Co Ltd46.58bn1.81bn45.90bn473.0025.382.2913.920.985536.1636.16931.59401.251.284.1413.8098,467,230.005.0510.839.2715.6526.1427.733.946.060.4352--0.460412.836.3812.07-17.419.3877.2413.65
France Bed Holdings Co Ltd59.15bn3.13bn47.65bn1.78k14.301.125.460.805686.7886.781,639.201,106.360.88783.245.8033,174,990.004.703.856.185.2453.9152.365.304.411.90--0.324144.960.97822.7015.993.81-1.019.30
Medikit Co Ltd21.85bn3.07bn52.69bn966.0015.540.988111.872.41189.68189.681,337.982,982.560.41953.664.0322,619,610.005.895.756.556.3140.0640.0514.0514.085.3512,203.360.017238.881.133.387.153.56-0.600512.20
Japan Eyewear Holdings Co Ltd14.47bn2.80bn74.35bn542.0026.655.4717.175.14116.51116.51601.39567.190.43712.2114.5026,699,260.008.47--10.42--77.60--19.38--1.3010.550.5555--26.17--659.25------
Tokai Corp (Gifu)138.22bn5.81bn80.62bn4.25k13.550.91397.650.5833165.03165.033,926.202,447.901.2219.076.9232,492,240.005.195.506.587.1124.3424.764.244.542.37--0.026427.316.173.51-4.852.9432.2914.09
Eiken Chemical Co Ltd40.05bn2.63bn84.64bn757.0031.141.6517.062.1170.5270.521,081.031,328.720.62622.833.4052,908,850.004.128.015.0610.1441.7645.926.5811.502.62--0.086235.45-7.442.29-54.08-5.2411.6611.20
Shofu Inc35.08bn3.66bn84.91bn1.37k23.132.0317.522.42205.19205.191,969.572,340.480.74781.519.2925,624,540.007.846.158.967.0059.8557.7610.488.122.66--0.010931.8410.747.0816.5924.935.0321.94
Japan Lifeline Co., Ltd.51.38bn7.52bn86.52bn1.22k11.591.479.631.6898.5598.55675.02775.420.69371.443.8842,256,580.0010.158.6312.5710.8860.3057.2814.6312.281.96--0.073948.80-0.70732.459.06-0.54465.407.69
Nagaileben Co., Ltd.16.64bn2.94bn90.70bn511.0027.551.8943.685.4592.1292.12520.881,344.120.3561.562.7032,564,670.006.297.716.748.3643.4745.3317.6720.3510.85----55.77-3.180.0433-14.61-2.58-20.390.00
HOGY MEDICAL CO., LTD.39.10bn2.80bn101.41bn1.41k34.751.1310.792.59115.55115.551,611.173,547.480.38672.844.9927,769,890.002.764.243.064.6733.4139.767.1411.584.07--0.061845.680.30531.30-35.03-14.247.944.56
Menicon Co Ltd116.19bn4.54bn101.56bn4.22k24.071.248.130.87455.0655.061,433.511,072.690.69933.059.1327,527,130.002.734.533.525.6752.5152.973.915.721.3420.670.463927.125.447.51-38.484.8832.6112.30
Data as of Jul 04 2024. Currency figures normalised to Shofu Inc's reporting currency: Japanese Yen JPY

Institutional shareholders

5.65%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 31 May 2024274.30k1.53%
Dimensional Fund Advisors LPas of 06 Jun 2024158.40k0.89%
Nikko Asset Management Co., Ltd.as of 07 Jun 2024131.90k0.74%
Daiwa Asset Management Co. Ltd.as of 31 May 2024124.80k0.70%
Goldman Sachs Asset Management LPas of 31 May 202481.00k0.45%
Sumitomo Mitsui DS Asset Management Co., Ltd.as of 06 Jun 202474.20k0.42%
Templeton Investment Counsel LLCas of 31 Mar 202466.30k0.37%
Mitsubishi UFJ Asset Management Co., Ltd.as of 07 Jun 202454.10k0.30%
Samarang LLPas of 30 Jun 202225.70k0.14%
Bessemer Investment Management LLCas of 31 Jan 202420.30k0.11%
More ▼
Data from 30 Jun 2022 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.